nav-left cat-right
cat-right

2nd Next Generation Sequencing & Bioinformati...

We welcome you to join us at GTCbio’s 2nd Next Generation Sequencing & Bioinformatics Conference on October 5-7, 2015 in Berlin, Germany. This conference gathers the foremost experts to present on leading-edge technology in next-generation sequencing and bioinformatics featuring discussions on opportunities and challenges in NGS, bioinformatics, and data management. Join your peers in this one-of-a-kind opportunity to...

Seegene Receives FDA Clearance for its Herpes Simp...

Gaithersburg, Maryland and SEOUL, Korea, February 17, 2015 – Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance for its TOCE™-based herpes simplex virus (HSV) types 1 and 2 assay. This is the first product that Seegene has taken through the FDA, and it opens the way for Seegene’s other...

2nd Metabolomics – Advances & Applicati...

GTCbio is proud to present the 2nd Metabolomics – Advances & Applications in Human Disease Conference, which will be part of The Pan-Omics Summit and takes place May 21-22, 2015 in Boston, MA. There is still significant human variability in metabolite identification for targets and pathways. These challenges affect the advancement in metabolomics, the use of biomarkers, and its application towards cancer, metabolic...

Pan Omics Summit May 21-22,2015 Boston, MA

We invite you to the attend the Pan-Omics Summit, which will take place May 21 – 22, 2015 in Boston, MA at the Hyatt Regency. This summit has four parallel tracks to discuss the developments and challenges in the popular omics areas of epigenomics, metabolomics, functional genomics, and next generation sequencing. Representatives from big pharma, academic institutions, and government research labs will present data on...

Seegene Receives US Patent for TOCE Technology

Gaithersburg, Maryland and SEOUL, Korea, November 19, 2014 – Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced that it has been issued a United States Patent, No. 8,809,239, for its tagging oligonucleotide capture and extension (TOCE™) technology, which enables highly multiplexed target amplification and detection in a single tube. TOCE™ technology is now IP protected in...

NIH lays out plan to work exome data into clinical...

Having seen the cost of exome sequencing tumble in recent years, the National Institutes of Health (NIH) has decided now is the time to jump-start its genomic medicine program. The upshot is more clinical research programs will soon have access to exome sequencing capabilities and NIH support with management of the resulting data. NIH has branded the two-year plan the Clinical Center Genomics Opportunity (CCGO) and committed...
Page 2 of 812345...Last »